Home/Filings/4/0001437749-21-003107
4//SEC Filing

Kaufman Joel H. 4

Accession 0001437749-21-003107

CIK 0000810509other

Filed

Feb 16, 7:00 PM ET

Accepted

Feb 17, 4:10 PM ET

Size

5.9 KB

Accession

0001437749-21-003107

Insider Transaction Report

Form 4
Period: 2021-02-15
Kaufman Joel H.
Chief Business Officer
Transactions
  • Award

    Stock Option

    2021-02-15$0.00/sh+25,000$2525,000 total
    Exercise: $2.56Exp: 2031-02-15Common Stock (25,000 underlying)
Holdings
  • Common Stock

    (indirect: By 401(k))
    9,648
Footnotes (1)
  • [F1]Stock options granted pursuant to Issuer's 2014 Amended and Restated Stock Incentive Plan, which vest as to one-third on each of the first three anniversaries of the date of grant.

Issuer

NAVIDEA BIOPHARMACEUTICALS, INC.

CIK 0000810509

Entity typeother

Related Parties

1
  • filerCIK 0001831425

Filing Metadata

Form type
4
Filed
Feb 16, 7:00 PM ET
Accepted
Feb 17, 4:10 PM ET
Size
5.9 KB